James Jenness - Kellanova Non-Executive Director
K Stock | USD 58.75 0.61 1.05% |
Director
Mr. James M. Jenness is NonExecutive Director of Kellogg Company. He has served as a Kellogg Director since July 2000. He was our Executive Chairman from February 2005 until June 2014, and served as our CEO from February 2005 through December 30, 2006. He also served as CEO of Integrated Merchandising Systems, LLC, a leader in outsource management of retail promotion and branded merchandising, from 1997 to December 2004. Before joining Integrated Merchandising Systems, Mr. Jenness served as Vice Chairman and COO of the Leo Burnett Company from 1996 to 1997 and, before that, as Global Vice Chairman North America and Latin America from 1993 to 1996. He is a director of KimberlyClark Corporation and Prestige Brands Holdings, Inc. Mr. Jenness also served as a trustee of the W.K. Kellogg Foundation Trust from 2005 to 2015. since 2014.
Age | 73 |
Tenure | 10 years |
Address | 412 North Wells Street, Chicago, IL, United States, 60654 |
Phone | 269 961 2000 |
Web | https://www.kellanova.com |
Kellanova Management Efficiency
The company has return on total asset of 0.0513 % which means that for every 100 dollars spent on assets, it generated a profit of $0.0513. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2035 %, implying that it made 0.2035 on every $100 invested by shareholders. Kellanova's management efficiency ratios could be used to measure how well Kellanova manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 0.15 this year. Return On Capital Employed is expected to rise to 0.29 this year. Change To Liabilities is expected to rise to about 496.3 M this year, although the value of Total Current Liabilities will most likely fall to about 3.2 B.Similar Executives
Found 12 records | DIRECTOR Age | ||
Jamie Bechtel | Arcadia Biosciences | N/A | |
Rajiv Shah | Arcadia Biosciences | 41 | |
Amy Yoder | Arcadia Biosciences | 51 | |
Matthew Ankrum | Arcadia Biosciences | 44 | |
Uday Garg | Arcadia Biosciences | 35 | |
James Reis | Arcadia Biosciences | 56 | |
Peter Gajdos | Arcadia Biosciences | 31 | |
Lilian Murray | Arcadia Biosciences | N/A | |
Kevin Comcowich | Arcadia Biosciences | 48 | |
George Gosbee | Arcadia Biosciences | 44 | |
Albert Bolles | Arcadia Biosciences | 60 | |
Gregory Waller | Arcadia Biosciences | 68 |
Management Performance
Return On Equity | 0.2 | ||||
Return On Asset | 0.0513 |
Kellanova Leadership Team
Elected by the shareholders, the Kellanova's board of directors comprises two types of representatives: Kellanova inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kellanova. The board's role is to monitor Kellanova's management team and ensure that shareholders' interests are well served. Kellanova's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kellanova's outside directors are responsible for providing unbiased perspectives on the board's policies.
CFA IV, Vice Planning | ||
Paul Norman, Sr. VP and President of North America | ||
Charisse Hughes, Senior Officer | ||
Gary Pilnick, Vice Chairman - Corporate Development and Chief Legal Officer | ||
Donald Mondano, Principal Accounting Officer, Vice President Corporate Controller | ||
Marcella Kain, Senior Director | ||
Mary Laschinger, Independent Director | ||
Lesley Salmon, Senior Officer | ||
Donald Knauss, Lead Independent Director | ||
Christopher Hood, Senior Vice President, President of Kellogg North America | ||
Nicolas Amaya, Senior Vice President and Presidentident, Kellogg Latin America | ||
Victor Cade, Senior America | ||
Doug Vandevelde, Senior Category | ||
Erica Mann, Independent Director | ||
Peter Rahal, President RX | ||
Fareed Khan, CFO | ||
Noel Wallace, Director | ||
Roderick Gillum, Independent Director | ||
Kurt Forche, Vice President Corporate Controller | ||
Maria Mejia, Senior Vice President and Presidentident, Kellogg Latin America | ||
Alistair Hirst, Senior Vice President - Global Supply Chain | ||
Richard Dreiling, Independent Director | ||
Ann Korologos, Independent Director | ||
John Bryant, Chairman, CEO and Chairman of Executive Committee | ||
John Min, Senior Secretary | ||
J Schlotman, Independent Director | ||
Joel Kooi, VP Treasurer | ||
Lauren Beck, Senior Relations | ||
Carter Cast, Independent Director | ||
Clive Sirkin, Senior Vice President Chief Growth Officer | ||
Melissa Howell, Senior Vice President - Global Human Services of the company | ||
Gordon Gund, Lead Independent Director | ||
Steven Cahillane, Chairman of the Board, President, Chief Executive Officer | ||
Rebecca Boustead, Director Pacific | ||
John Dillon, Independent Director | ||
Shumit Kapoor, Senior Vice President and Presidentident - Kellogg Asia Pacific, Middle East and Africa | ||
James Jenness, Non-Executive Director | ||
Stephanie Burns, Independent Director | ||
La Tabron, Independent Director | ||
Ronald Dissinger, CFO and Sr. VP | ||
David Lawlor, Senior Vice President, President, Kellogg Europe | ||
Zachary Gund, Independent Director | ||
G Gund, Independent Director | ||
Amit Banati, Senior Vice President and Presidentident, Asia Pacific | ||
Michael Hunter, VP Sales | ||
Rogelio Rebolledo, Independent Director | ||
Cynthia Milligan, Independent Director | ||
Carolyn Tastad, Independent Director | ||
Monica McGurk, Senior Vice President Chief Growth Officer | ||
Kris Bahner, Senior Officer | ||
Rodrigo Lance, Senior Vice President - Global Supply Chain | ||
Samantha Long, Senior Vice President - Global Human Resources |
Kellanova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kellanova a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.2 | ||||
Return On Asset | 0.0513 | ||||
Profit Margin | 0.07 % | ||||
Operating Margin | 0.13 % | ||||
Current Valuation | 26.45 B | ||||
Shares Outstanding | 341.76 M | ||||
Shares Owned By Insiders | 0.94 % | ||||
Shares Owned By Institutions | 87.53 % | ||||
Number Of Shares Shorted | 11.39 M | ||||
Price To Earning | 16.74 X |
Kellanova Investors Sentiment
The influence of Kellanova's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Kellanova. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Kellanova's public news can be used to forecast risks associated with an investment in Kellanova. The trend in average sentiment can be used to explain how an investor holding Kellanova can time the market purely based on public headlines and social activities around Kellanova. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Kellanova's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Kellanova's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Kellanova's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Kellanova.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kellanova in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kellanova's short interest history, or implied volatility extrapolated from Kellanova options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kellanova. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Kellanova Stock please use our How to buy in Kellanova Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Kellanova Stock analysis
When running Kellanova's price analysis, check to measure Kellanova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kellanova is operating at the current time. Most of Kellanova's value examination focuses on studying past and present price action to predict the probability of Kellanova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kellanova's price. Additionally, you may evaluate how the addition of Kellanova to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Kellanova's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kellanova. If investors know Kellanova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kellanova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 2.34 | Earnings Share 2.25 | Revenue Per Share 38.359 | Quarterly Revenue Growth (0.17) |
The market value of Kellanova is measured differently than its book value, which is the value of Kellanova that is recorded on the company's balance sheet. Investors also form their own opinion of Kellanova's value that differs from its market value or its book value, called intrinsic value, which is Kellanova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kellanova's market value can be influenced by many factors that don't directly affect Kellanova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kellanova's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kellanova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kellanova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.